Skip to Content

Business Plan Development for Early Stage Specialty Pharma Company


Case Study


Scenario: 
  • Newly incorporated specialty pharma company needs business plan and commercialization strategy for two novel lead drug candidates targeting different cardiovascular indications.
Background:
  • Company founded by ex pharma researchers with strong IP position on a series of compounds with novel pharmacokinetic properties to overcome commonly seen adverse events and efficacy limitations of lipid lowering and antihypertensive therapies
  • Company needed business planning and development support, and requested assistance with the writing of a business plan
  • Company was seeking to raise VC funding prior to commencement of pre-clinical development
Objectives:
  • Develop and write business plan
  • Refine business strategy
  • Explore options for conducting IND enabling pre-clinical studies
  • Develop outlicensing goals and strategy
  • Conduct market opportunity assessment and competitive analysis
  • Explore risks, revenue, and profit opportunities for clinical development and outlicensing of lead candidates
Approach:
  • Review literature, secondary data and syndicated market reports
  • Identify opportunities and resources to support pre-clinical development
  • Define target market, value proposition, current competitors and key competitive drugs in development
  • Develop target product profile and commercial needs for clinical development
  • Construct early stage demand projections and financial projections based on target product profile, risk, and anticipated market scenarios
  • Write draft of business plan for management review
Key Outcomes:
  • Developed and wrote business plan
  • Identified clinical development consulting partner, made introductions, and managed interactions between partner and company
  • Identified potential pharmacogenomics partner for possible collaboration in the development of a complementary diagnostic test to support commercialization of one of lead candidates.
  • Developed patient Rx demand and financial NPV models to evaluate changing assumptions and  “what if scenarios”
Impact:
  • Business plan provided foundation for developing investor presentation and operational plans
  • Company was able to raise venture capital funding in the midst of a challenging economic climate